Article
22 Jun 2026
Class Action Launched Over Alleged Defects In Pacemakers
RANKINGS
This author falls within the Top 20% for their listed topics and industry categories. Based on Mondaq users readership, this author is ranked as VERY POPULAR in Canada
AUTHORS CONTENT
Article
13 Apr 2026
Class Action Pursued Over Infection Risks Linked To Endoscope Devices
Article
12 Jan 2026
Class Action Pursued Concerning Safety Defects With GLP-1 Drugs Mounjaro, Trulicity, & Zepbound
Article
07 Jan 2026
Cancer-linked Drug And Product Lawsuits: Legal Pathways For Affected Patients
Article
12 Dec 2025
How To Find The Risks Linked To Your Prescriptions
Article
02 Dec 2025
Ozempic, A Diabetes Drug Linked To Gastrointestinal Issues And Vision Loss, Approved To Treat Kidney Issues
Article
14 Apr 2025
US Court Rejects Johnson & Johnson Bankruptcy Bid
Article
11 Dec 2024
Settlement Announced In US Hernia Mesh Litigation
Article
23 Oct 2024
New Warnings For Gastroparesis, Severe Stomach Problems Added To Popular GLP-1 Drugs
Article
11 Jul 2024
Suboxone Tooth Decay Lawsuits On The Rise In North America
Article
08 Jul 2024
Canadian Cook IVC Settlement Now Open To Claims
Article
29 Apr 2024
Opioid Treatment Drug Suboxone Linked To Tooth Decay
Article
11 Mar 2024
Canadians Who Spent Time At Camp Lejeune In Jacksonville, North Carolina May Be Eligible For Compensation
Article
06 Nov 2023
Class Action Pursued For Canadians Alleging Harms From Ozempic, Semaglutide Drugs
Article
24 Oct 2023
Bard PowerPort Catheters: Device Failures Linked To Health Risks
Article
24 Aug 2023
Ozempic For Weight Loss? Know The Risks Of Off-Label Prescriptions
Article
10 Aug 2023
Bladder Drug Elmiron – Linked To Vision Loss, Macular Degeneration – Still Among Top Non-Patented Drugs In Canada Per 2023 Report
Article
27 Jul 2023
Xeljanz, Linked To Heart Attacks, Blood Clots, And Cancers – Is Now Approved To Treat Arthritis Of The Spine
Article
11 Jul 2023
Newly Released J&J Bankruptcy Plan For Compensating Talcum Powder Cancer Claims Includes Canadian Claims
Article
30 May 2023
Canadians Can Now Claim Under $20 Million OxyContin Class Actions Settlement